NEW YORK (Reuters Health) - Carbohydrate content might be less important for blood sugar control than glycemic load, according to a new study of healthy adults.
The study questions the way patients with type 1 diabetes determine how much insulin they should take before meals.
Jiansong Bao at the University of Sydney in Australia and colleagues took finger-prick blood samples from 10 healthy young people who ate a total of 120 different types of food -- all with the same calorie content.
The glycemic load repeatedly trumped the carb count in predicting the blood sugar and insulin rise after a meal.
"It suggests that the methods used to assess carbs in persons with type 1 diabetes might benefit from some rethinking," said Dr. Edward J. Boyko, a diabetes expert at the University of Washington in Seattle who wasn't involved in the study.
But he said it wasn't certain the findings would hold up in people who aren't completely healthy.
"In the U.S., 60% of people are overweight or obese so we don't know how the results would apply to them or to persons with diabetes," he told Reuters Health.
The glycemic load is calculated by multiplying the amount of carbs in grams per serving by the food's glycemic index divided by 100. The glycemic index for a variety of foods can be found at http://www.glycemicindex.com/.
Foods with a low glycemic index cause the blood sugar to rise slowly.
Writing online February 16th in the American Journal of Clinical Nutrition, the researchers say their findings also suggest that eating foods with high glycemic loads could be linked to chronic disease like type 2 diabetes and heart disease.
But that is not clear from the study, which only looked at blood sugar and insulin changes up to two hours after a meal, said Dr. Boyko.
"It would just be speculation whether a dietary change like this would help people with type 2 diabetes," he told Reuters Health.
Long-term effects and other nutrients in the food might also be important for disease risk, for instance. And the most important problem remains pure and simple overeating, according to Dr. Boyko.
"The excess weight is the main thing we ought to focus on," he said. "The simplest message would be, eat less."
SOURCE: http://bit.ly/dYj8jN
Am J Clin Nutr 2011.
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Monday, March 14, 2011
Study challenges carb counting in diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment